Atrium Innovations Inc. — Investor Relations & Filings
Filings indexed
66
across all filing types
Latest filing
2014-03-06
Regulatory Filings
Country
CA
Canada
Listing
TSX
ATB
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products. The company's portfolio primarily consists of nutritional and dietary supplements, including specialized products, vitamins, and minerals, alongside certain cosmetic and chemical formulations. Atrium focuses on delivering professionally endorsed solutions that support a holistic approach to individualized health and healing. A key component of its operations includes providing educational resources, such as expert-led webinars, focused on advancing knowledge in natural medicine and nutrition science for healthcare practitioners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other securityholders documents - English.pdf | 2014-03-06 | English | |
| Other securityholders documents - English.pdf | 2014-02-14 | English | |
| Material change report - French.pdf | 2014-02-14 | English | |
| Other.pdf | 2013-12-10 | English | |
| Other.pdf | 2013-12-10 | English | |
| Material change report - French.pdf | 2013-12-10 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2014
3 filings
| |||||
| 47171854 | Other securityholders documents - English.pdf | 2014-03-06 | English | ||
| 47171858 | Other securityholders documents - English.pdf | 2014-02-14 | English | ||
| 47171862 | Material change report - French.pdf | 2014-02-14 | English | ||
|
2013
7 filings
| |||||
| 47171882 | Other.pdf | 2013-12-10 | English | ||
| 47171893 | Other.pdf | 2013-12-10 | English | ||
| 47171897 | Material change report - French.pdf | 2013-12-10 | English | ||
| 47171919 | Material change report - English.pdf | 2013-10-23 | English | ||
| 47171926 | Other.pdf | 2013-10-18 | English | ||
| 47171948 | Material change report - English.pdf | 2013-10-18 | English | ||
| 47171952 | Annual information form - English.pdf | 2013-03-29 | English | ||
|
2012
2 filings
| |||||
| 47171959 | Annual information form - English.pdf | 2012-03-31 | English | ||
| 47171984 | Other.pdf | 2012-03-31 | English | ||
|
2011
3 filings
| |||||
| 47171990 | Material change report - French.pdf | 2011-10-11 | English | ||
| 47172250 | Other.pdf | 2011-09-29 | English | ||
| 47172252 | Material change report - English.pdf | 2011-08-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
Atrium Innovations Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45568/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45568 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45568 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45568 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45568}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Atrium Innovations Inc. (id: 45568)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.